Search - tctmd.com

Displaying 81 - 100 of 196

Sort: Relevancy | Date

Presentation TCT 2016

Outcome Registries IV: The UK Absorb Registry

Presenter: Stephen G. Ellis, Corrado Tamburino, Andreas Baumbach

October 31, 2016

Presentation TCT 2016

Outcome Registries III: 2-Year Results From ASSURE

Presenter: Stephen G. Ellis, Corrado Tamburino, Detlef G. Mathey

October 31, 2016

Presentation TCT 2016

Outcome Registries II: Long-term Outcomes From ABSORB EXPAND and STEMI First

Presenter: Stephen G. Ellis, Corrado Tamburino, Robert-Jan van Geuns

October 31, 2016

Presentation TCT 2016

Outcome Registries I: Extended Results From ABSORB EXTEND

Presenter: Stephen G. Ellis, Corrado Tamburino, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

ABSORB China Clinical Outcomes at 2 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Runlin Gao

October 31, 2016

Presentation TCT 2016

ABSORB II Clinical Outcomes at 3 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Bernard R. Chevalier

October 31, 2016

Presentation TCT 2016

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Presenter: Stephen G. Ellis, Corrado Tamburino, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials

Presenter: Antonio L. Bartorelli, Kenneth Chin, Ariel Furer

October 31, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

Absorb BVS 的 18 个月结果“令人安心”，但仍需要更长期的随访

Michael O'Riordan

August 01, 2016

News Daily News

“Tranquilizadores” Resultados a 18 Meses con el AVB Absorb Aunque Todavía Necesitamos Seguimientos Más Largos

Michael O'Riordan

August 01, 2016

News Daily News

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Michael O'Riordan

August 01, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Daily News

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Michael O'Riordan

June 14, 2016

News Daily News

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Michael O'Riordan

June 06, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Daily News

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

Michael O'Riordan

June 06, 2016

Advertisement

Outcome Registries IV: The UK Absorb Registry

Outcome Registries III: 2-Year Results From ASSURE

Outcome Registries II: Long-term Outcomes From ABSORB EXPAND and STEMI First

Outcome Registries I: Extended Results From ABSORB EXTEND

ABSORB China Clinical Outcomes at 2 Years

ABSORB II Clinical Outcomes at 3 Years

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials

TCTMD’s Top 10 Most Popular Stories for August 2016

The Bioresorbable Stent Story So Far: What Promise? What Price?

Absorb BVS 的 18 个月结果“令人安心”，但仍需要更长期的随访

“Tranquilizadores” Resultados a 18 Meses con el AVB Absorb Aunque Todavía Necesitamos Seguimientos Más Largos

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

TCTMD’s Top 10 Most Popular Stories for June 2016

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content